<- Go Home

Tivic Health Systems, Inc.

Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its commercial product under the ClearUP Sinus Pain Relief brand name. It also focusses on non-invasive vagus nerve stimulation. The company was incorporated in 2016 and is based in Fremont, California.

Market Cap

N/A

Volume

N/A

Cash and Equivalents

$3.5M

EBITDA

-$7.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$280.0K

Profit Margin

58.09%

52 Week High

N/A

52 Week Low

N/A

Dividend

N/A

Price / Book Value

N/A

Price / Earnings

N/A

Price / Tangible Book Value

N/A

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$7.4M

Return on Equity

178.18%

Return on Assets

-96.20

Cash and Short Term Investments

$3.5M

Debt

N/A

Equity

$5.6M

Revenue

$482.0K

Unlevered FCF

-$4.1M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches